These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 15061774)

  • 1. Innate versus adaptive immunity in Candida albicans infection.
    Ashman RB; Farah CS; Wanasaengsakul S; Hu Y; Pang G; Clancy RL
    Immunol Cell Biol; 2004 Apr; 82(2):196-204. PubMed ID: 15061774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and pathologic immune responses against Candida albicans infection.
    Ashman RB
    Front Biosci; 2008 May; 13():3334-51. PubMed ID: 18508436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.
    Bishu S; Hernández-Santos N; Simpson-Abelson MR; Huppler AR; Conti HR; Ghilardi N; Mamo AJ; Gaffen SL
    Infect Immun; 2014 Mar; 82(3):1173-80. PubMed ID: 24379290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Defensin 1 plays a role in acute mucosal defense against Candida albicans.
    Tomalka J; Azodi E; Narra HP; Patel K; O'Neill S; Cardwell C; Hall BA; Wilson JM; Hise AG
    J Immunol; 2015 Feb; 194(4):1788-95. PubMed ID: 25595775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired immunity to systemic candidiasis in immunodeficient mice.
    Cantorna MT; Balish E
    J Infect Dis; 1991 Nov; 164(5):936-43. PubMed ID: 1940472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions.
    Krause MW; Schaffner A
    Infect Immun; 1989 Nov; 57(11):3472-8. PubMed ID: 2807532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking into Candida albicans infection, host response, and antifungal strategies.
    Wang Y
    Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-33 Coordinates Innate Defense to Systemic
    Nguyen NZN; Tran VG; Baek J; Kim Y; Youn EH; Na SW; Park SJ; Seo SK; Kwon B
    J Immunol; 2022 Feb; 208(3):660-671. PubMed ID: 35022276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis.
    Farah CS; Elahi S; Pang G; Gotjamanos T; Seymour GJ; Clancy RL; Ashman RB
    Infect Immun; 2001 Oct; 69(10):6110-8. PubMed ID: 11553549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis.
    Navarathna DH; Stein EV; Lessey-Morillon EC; Nayak D; Martin-Manso G; Roberts DD
    PLoS One; 2015; 10(5):e0128220. PubMed ID: 26010544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host response to Candida albicans bloodstream infection and sepsis.
    Duggan S; Leonhardt I; Hünniger K; Kurzai O
    Virulence; 2015; 6(4):316-26. PubMed ID: 25785541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.
    Goupil M; Cousineau-Côté V; Aumont F; Sénéchal S; Gaboury L; Hanna Z; Jolicoeur P; de Repentigny L
    BMC Immunol; 2014 Oct; 15():49. PubMed ID: 25344377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.
    Salvatori O; Puri S; Tati S; Edgerton M
    J Dent Res; 2016 Apr; 95(4):365-71. PubMed ID: 26747422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial cells and innate antifungal defense.
    Weindl G; Wagener J; Schaller M
    J Dent Res; 2010 Jul; 89(7):666-75. PubMed ID: 20395411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immune cell response upon Candida albicans infection.
    Qin Y; Zhang L; Xu Z; Zhang J; Jiang YY; Cao Y; Yan T
    Virulence; 2016 Jul; 7(5):512-26. PubMed ID: 27078171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.
    Farah CS; Hu Y; Riminton S; Ashman RB
    Oral Microbiol Immunol; 2006 Aug; 21(4):252-5. PubMed ID: 16842510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections through Induction of IL-13 Production by CD4+ T Cells.
    Tran VG; Kim HJ; Kim J; Kang SW; Moon UJ; Cho HR; Kwon B
    J Immunol; 2015 May; 194(10):4871-9. PubMed ID: 25847973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive immune responses to Candida albicans infection.
    Richardson JP; Moyes DL
    Virulence; 2015; 6(4):327-37. PubMed ID: 25607781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.